16-74661181-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018124.4(RFWD3):​c.269C>A​(p.Thr90Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.687 in 1,614,032 control chromosomes in the GnomAD database, including 383,635 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T90A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.73 ( 41146 hom., cov: 33)
Exomes 𝑓: 0.68 ( 342489 hom. )

Consequence

RFWD3
NM_018124.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.40

Publications

48 publications found
Variant links:
Genes affected
RFWD3 (HGNC:25539): (ring finger and WD repeat domain 3) Enables MDM2/MDM4 family protein binding activity; p53 binding activity; and ubiquitin protein ligase activity. Involved in several processes, including DNA metabolic process; regulation of cell cycle phase transition; and response to ionizing radiation. Located in nucleoplasm and site of DNA damage. Colocalizes with site of double-strand break. Implicated in Fanconi anemia. [provided by Alliance of Genome Resources, Apr 2022]
RFWD3 Gene-Disease associations (from GenCC):
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia, complementation group W
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.974846E-7).
BP6
Variant 16-74661181-G-T is Benign according to our data. Variant chr16-74661181-G-T is described in ClinVar as Benign. ClinVar VariationId is 1327954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.835 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RFWD3NM_018124.4 linkc.269C>A p.Thr90Asn missense_variant Exon 2 of 13 ENST00000361070.9 NP_060594.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RFWD3ENST00000361070.9 linkc.269C>A p.Thr90Asn missense_variant Exon 2 of 13 1 NM_018124.4 ENSP00000354361.4

Frequencies

GnomAD3 genomes
AF:
0.730
AC:
111077
AN:
152070
Hom.:
41105
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.843
Gnomad AMI
AF:
0.764
Gnomad AMR
AF:
0.750
Gnomad ASJ
AF:
0.576
Gnomad EAS
AF:
0.813
Gnomad SAS
AF:
0.803
Gnomad FIN
AF:
0.640
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.668
Gnomad OTH
AF:
0.723
GnomAD2 exomes
AF:
0.712
AC:
179034
AN:
251426
AF XY:
0.709
show subpopulations
Gnomad AFR exome
AF:
0.843
Gnomad AMR exome
AF:
0.780
Gnomad ASJ exome
AF:
0.571
Gnomad EAS exome
AF:
0.814
Gnomad FIN exome
AF:
0.643
Gnomad NFE exome
AF:
0.665
Gnomad OTH exome
AF:
0.689
GnomAD4 exome
AF:
0.682
AC:
997263
AN:
1461844
Hom.:
342489
Cov.:
73
AF XY:
0.684
AC XY:
497315
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.846
AC:
28327
AN:
33480
American (AMR)
AF:
0.774
AC:
34619
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.580
AC:
15147
AN:
26136
East Asian (EAS)
AF:
0.806
AC:
31982
AN:
39700
South Asian (SAS)
AF:
0.778
AC:
67065
AN:
86256
European-Finnish (FIN)
AF:
0.644
AC:
34392
AN:
53392
Middle Eastern (MID)
AF:
0.674
AC:
3890
AN:
5768
European-Non Finnish (NFE)
AF:
0.666
AC:
740233
AN:
1111992
Other (OTH)
AF:
0.689
AC:
41608
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
20605
41210
61814
82419
103024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19310
38620
57930
77240
96550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.731
AC:
111178
AN:
152188
Hom.:
41146
Cov.:
33
AF XY:
0.733
AC XY:
54514
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.843
AC:
35011
AN:
41540
American (AMR)
AF:
0.750
AC:
11469
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.576
AC:
1998
AN:
3468
East Asian (EAS)
AF:
0.812
AC:
4202
AN:
5172
South Asian (SAS)
AF:
0.803
AC:
3873
AN:
4826
European-Finnish (FIN)
AF:
0.640
AC:
6773
AN:
10582
Middle Eastern (MID)
AF:
0.629
AC:
185
AN:
294
European-Non Finnish (NFE)
AF:
0.668
AC:
45444
AN:
67998
Other (OTH)
AF:
0.725
AC:
1529
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1493
2987
4480
5974
7467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.685
Hom.:
153075
Bravo
AF:
0.741
TwinsUK
AF:
0.660
AC:
2448
ALSPAC
AF:
0.679
AC:
2615
ESP6500AA
AF:
0.829
AC:
3645
ESP6500EA
AF:
0.671
AC:
5773
ExAC
AF:
0.714
AC:
86665
Asia WGS
AF:
0.814
AC:
2828
AN:
3478
EpiCase
AF:
0.659
EpiControl
AF:
0.666

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Fanconi anemia, complementation group W Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.79
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.0020
DANN
Benign
0.13
DEOGEN2
Benign
0.0022
T;T;.;.;.
Eigen
Benign
-2.2
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.0
.;T;T;T;T
MetaRNN
Benign
8.0e-7
T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-1.2
N;N;.;.;.
PhyloP100
-2.4
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.93
N;.;.;.;.
REVEL
Benign
0.012
Sift
Benign
1.0
T;.;.;.;.
Sift4G
Benign
1.0
T;T;.;.;.
Vest4
0.0080
ClinPred
0.019
T
GERP RS
-9.5
Varity_R
0.053
gMVP
0.067
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8058922; hg19: chr16-74695079; COSMIC: COSV107456470; COSMIC: COSV107456470; API